Stopping Renin-Angiotensin System Inhibitors in Chronic Kidney Disease: Predictors of Response | Zendy

Anderson Gonçalves | Zendy; Arif Khwaja | Zendy; Aimune K. Ahmed | Zendy; Mohsen El Kossi | Zendy; Meguid El Nahas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stopping Renin-Angiotensin System Inhibitors in Chronic Kidney Disease: Predictors of Response

Author(s) -

Anderson Gonçalves,

Arif Khwaja,

Aimune K. Ahmed,

Mohsen El Kossi,

Meguid El Nahas

Publication year - 2011

Publication title -

nephron clinical practice

Language(s) - English

Resource type - Journals

ISSN - 1660-2110

DOI - 10.1159/000330289

Subject(s) - medicine , kidney disease , renal function , urology , renal replacement therapy , renin–angiotensin system , angiotensin ii , kidney , gastroenterology , endocrinology , blood pressure

Renin-angiotensin system (RAS) inhibitors are considered first-line agents for hypertensive patients with progressive chronic kidney disease (CKD). In a previous study, we showed that stopping RAS inhibitors increased estimated glomerular filtration rate (eGFR) in a significant number of advanced CKD patients. The present study tries to address who would benefit and whether this benefit is predictable.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research